Adriblastin Solution 10 mg/5 ml
Adriblastin Solution 10 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 50358. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 June 1991 and the authorisation is valid without a time limit. ATC code L01DB01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 50358 |
|---|---|
| Name | Adriblastin Solution 10 mg/5 ml |
| Full name | Adriblastin Solution 10 mg/5 ml, Injektionslösung |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01DB01 |
| First authorisation | 24 June 1991 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Adriblastin Solution 10 mg/5 ml, Injektionslösung | A | 24 June 1991 |
| 2 | Adriblastin Solution 20 mg/10 ml, Injektionslösung | A | 24 June 1991 |
| 3 | Adriblastin Solution 50 mg/25 ml, Injektionslösung | A | 24 June 1991 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 54 | 1 | Durchstechflasche(n) | L01DB01 | 07.16.1. | A |
| 62 | 1 | Durchstechflasche(n) | L01DB01 | 07.16.1. | A |
| 70 | 2 | Durchstechflasche(n) | L01DB01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Adriblastin Solution 10 mg/5 ml authorised in Switzerland?
Yes. Adriblastin Solution 10 mg/5 ml is authorised by Swissmedic under authorisation number 50358, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Adriblastin Solution 10 mg/5 ml have?
Adriblastin Solution 10 mg/5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Adriblastin Solution 10 mg/5 ml?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.